North Star Investment Management Corp.
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1342857
CHICAGO, IL
Position in XERS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$7,920
New position
Shares Held
1,000
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 34 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026North Star Investment Management Corp. holds $1,919,297 across 19 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
19,483 | $1,400,048 | |
| 2 | ESPR |
Esperion Therapeutics, Inc.
|
45,000 | $142,200 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,311 | $112,176 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
201 | $108,907 | |
| 5 | VTRS |
Viatris Inc
|
5,492 | $87,212 | |
| 6 | TRLV |
Trulieve Cannabis Corp.
|
2,600 | $25,558 | |
| 7 | HLN |
Haleon plc
|
1,183 | $11,037 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
1,000 | $7,920 |
All Filings in XERS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,920 | 1,000 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||